Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.

Banerjee A, Macdonald ML, Borgmann-Winter KE, Hahn CG.

Brain Res Bull. 2010 Sep 30;83(3-4):132-9. doi: 10.1016/j.brainresbull.2010.04.011. Epub 2010 Apr 28. Review.

PMID:
20433909
2.

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia.

Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE.

Nat Med. 2006 Jul;12(7):824-8. Epub 2006 Jun 11.

PMID:
16767099
3.

Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.

du Bois TM, Newell KA, Huang XF.

Eur Neuropsychopharmacol. 2012 May;22(5):356-63. doi: 10.1016/j.euroneuro.2011.09.002. Epub 2011 Oct 1.

PMID:
21962913
4.

Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Deng C, Pan B, Engel M, Huang XF.

Psychopharmacology (Berl). 2013 Mar;226(2):201-15. doi: 10.1007/s00213-013-3003-2. Epub 2013 Feb 7. Review.

PMID:
23389757
5.

A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.

Newell KA, Karl T, Huang XF.

Neuroscience. 2013 Sep 17;248:670-80. doi: 10.1016/j.neuroscience.2013.06.037. Epub 2013 Jun 27.

PMID:
23811072
6.

Antipsychotic treatment and neuregulin 1-ErbB4 signalling in schizophrenia.

Pan B, Huang XF, Deng C.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):924-30. doi: 10.1016/j.pnpbp.2011.04.002. Epub 2011 Apr 13. Review.

PMID:
21513767
7.

Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

Pitcher GM, Kalia LV, Ng D, Goodfellow NM, Yee KT, Lambe EK, Salter MW.

Nat Med. 2011 Apr;17(4):470-8. doi: 10.1038/nm.2315. Epub 2011 Mar 27.

8.

Schizophrenia: more evidence for less glutamate.

Morrison PD, Pilowsky LS.

Expert Rev Neurother. 2007 Jan;7(1):29-31.

PMID:
17187494
9.

Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.

Buxbaum JD, Georgieva L, Young JJ, Plescia C, Kajiwara Y, Jiang Y, Moskvina V, Norton N, Peirce T, Williams H, Craddock NJ, Carroll L, Corfas G, Davis KL, Owen MJ, Harroch S, Sakurai T, O'Donovan MC.

Mol Psychiatry. 2008 Feb;13(2):162-72. Epub 2007 Apr 17.

PMID:
17579610
10.

Reciprocal signalling between NR2 subunits of the NMDA receptor and neuregulin1 and their role in schizophrenia.

Geddes AE, Huang XF, Newell KA.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):896-904. doi: 10.1016/j.pnpbp.2011.02.017. Epub 2011 Mar 1. Review.

PMID:
21371516
11.

The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons.

Allison JG, Das PM, Ma J, Inglis FM, Jones FE.

Neurosci Res. 2011 Jun;70(2):155-63. doi: 10.1016/j.neures.2011.02.009. Epub 2011 Feb 23.

PMID:
21352860
12.

Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Nicodemus KK, Law AJ, Radulescu E, Luna A, Kolachana B, Vakkalanka R, Rujescu D, Giegling I, Straub RE, McGee K, Gold B, Dean M, Muglia P, Callicott JH, Tan HY, Weinberger DR.

Arch Gen Psychiatry. 2010 Oct;67(10):991-1001. doi: 10.1001/archgenpsychiatry.2010.117.

13.

Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Mei L, Xiong WC.

Nat Rev Neurosci. 2008 Jun;9(6):437-52. doi: 10.1038/nrn2392. Epub 2008 May 14. Review.

14.

Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Norton N, Moskvina V, Morris DW, Bray NJ, Zammit S, Williams NM, Williams HJ, Preece AC, Dwyer S, Wilkinson JC, Spurlock G, Kirov G, Buckland P, Waddington JL, Gill M, Corvin AP, Owen MJ, O'Donovan MC.

Am J Med Genet B Neuropsychiatr Genet. 2006 Jan 5;141B(1):96-101.

PMID:
16249994
15.

Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression.

Bennett M.

Aust N Z J Psychiatry. 2009 Aug;43(8):711-21. doi: 10.1080/00048670903001943. Review.

PMID:
19629792
16.
17.

Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.

Bjarnadottir M, Misner DL, Haverfield-Gross S, Bruun S, Helgason VG, Stefansson H, Sigmundsson A, Firth DR, Nielsen B, Stefansdottir R, Novak TJ, Stefansson K, Gurney ME, Andresson T.

J Neurosci. 2007 Apr 25;27(17):4519-29.

18.

Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activation.

Pregno G, Zamburlin P, Gambarotta G, Farcito S, Licheri V, Fregnan F, Perroteau I, Lovisolo D, Bovolin P.

BMC Neurosci. 2011 Oct 12;12:103. doi: 10.1186/1471-2202-12-103.

19.

Neuregulin 1 and schizophrenia.

Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K.

Ann Med. 2004;36(1):62-71. Review.

PMID:
15000348
20.

ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation.

Chen YJ, Zhang M, Yin DM, Wen L, Ting A, Wang P, Lu YS, Zhu XH, Li SJ, Wu CY, Wang XM, Lai C, Xiong WC, Mei L, Gao TM.

Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21818-23. doi: 10.1073/pnas.1010669107. Epub 2010 Nov 24.

Items per page

Supplemental Content

Write to the Help Desk